445 related articles for article (PubMed ID: 29961079)
1. Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer.
Shu Y; Zhang W; Hou Q; Zhao L; Zhang S; Zhou J; Song X; Zhang Y; Jiang D; Chen X; Wang P; Xia X; Liao F; Yin D; Chen X; Zhou X; Zhang D; Yin S; Yang K; Liu J; Fu L; Zhang L; Wang Y; Zhang J; An Y; Cheng H; Zheng B; Sun H; Zhao Y; Wang Y; Xie D; Ouyang L; Wang P; Zhang W; Qiu M; Fu X; Dai L; He G; Yang H; Cheng W; Yang L; Liu B; Li W; Dong B; Zhou Z; Wei Y; Peng Y; Xu H; Hu J
Nat Commun; 2018 Jun; 9(1):2447. PubMed ID: 29961079
[TBL] [Abstract][Full Text] [Related]
2. Recurrent Fusion Genes in Gastric Cancer: CLDN18-ARHGAP26 Induces Loss of Epithelial Integrity.
Yao F; Kausalya JP; Sia YY; Teo AS; Lee WH; Ong AG; Zhang Z; Tan JH; Li G; Bertrand D; Liu X; Poh HM; Guan P; Zhu F; Pathiraja TN; Ariyaratne PN; Rao J; Woo XY; Cai S; Mulawadi FH; Poh WT; Veeravalli L; Chan CS; Lim SS; Leong ST; Neo SC; Choi PS; Chew EG; Nagarajan N; Jacques PÉ; So JB; Ruan X; Yeoh KG; Tan P; Sung WK; Hunziker W; Ruan Y; Hillmer AM
Cell Rep; 2015 Jul; 12(2):272-85. PubMed ID: 26146084
[TBL] [Abstract][Full Text] [Related]
3. Highly expressed Claudin18.2 as a potential therapeutic target in advanced gastric signet-ring cell carcinoma (SRCC).
Xu B; Liu F; Liu Q; Shi T; Wang Z; Wu N; Xu X; Li L; Fan X; Yu L; Liu B; Wei J
J Gastrointest Oncol; 2020 Dec; 11(6):1431-1439. PubMed ID: 33457012
[TBL] [Abstract][Full Text] [Related]
4. Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer.
Zhang F; Sahu V; Peng K; Wang Y; Li T; Bala P; Aitymbayev D; Sahgal P; Schaefer A; Der CJ; Ryeom S; Yoon S; Sethi N; Bass AJ; Zhang H
Gut; 2024 Apr; ():. PubMed ID: 38621923
[TBL] [Abstract][Full Text] [Related]
5. The Significance of the
Zhang WH; Zhang SY; Hou QQ; Qin Y; Chen XZ; Zhou ZG; Shu Y; Xu H; Hu JK
Front Oncol; 2020; 10():1214. PubMed ID: 32983960
[No Abstract] [Full Text] [Related]
6. Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study.
Pernot S; Dubreuil O; Aparicio T; Le Malicot K; Tougeron D; Lepère C; Lecaille C; Marthey L; Palle J; Bachet JB; Zaanan A; Taieb J
Br J Cancer; 2018 Aug; 119(4):424-428. PubMed ID: 29872148
[TBL] [Abstract][Full Text] [Related]
7. Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis-a cohort study of 123 patients from a non-endemic country.
Zaafouri H; Jouini R; Khedhiri N; Khanchel F; Cherif M; Mesbahi M; Daghmouri A; Mahmoudi W; Akremi S; Sabbah M; Benzarti Y; Hadded D; Gargouri D; Bader MB; Maamer AB
World J Surg Oncol; 2022 Jul; 20(1):238. PubMed ID: 35858903
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the expression and genetic alteration of CLDN18 in gastric cancer.
Li J; Zhang Y; Hu D; Gong T; Xu R; Gao J
Aging (Albany NY); 2020 Jul; 12(14):14271-14284. PubMed ID: 32668412
[TBL] [Abstract][Full Text] [Related]
9. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge.
Pernot S; Voron T; Perkins G; Lagorce-Pages C; Berger A; Taieb J
World J Gastroenterol; 2015 Oct; 21(40):11428-38. PubMed ID: 26523107
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of docetaxel- and oxaliplatin-based adjuvant chemotherapy in postgastrectomy gastric cancer patients reveals obvious survival benefits in docetaxel-treated mixed signet ring cell carcinoma patients.
Chen L; Shi Y; Yuan J; Wu Q; Han Y; Qin R; Jia B; Wei B; Wei L; Dai G; Jiao S
Med Oncol; 2014 Sep; 31(9):159. PubMed ID: 25119501
[TBL] [Abstract][Full Text] [Related]
11. Enrichment of CLDN18-ARHGAP fusion gene in gastric cancers in young adults.
Nakayama I; Shinozaki E; Sakata S; Yamamoto N; Fujisaki J; Muramatsu Y; Hirota T; Takeuchi K; Takahashi S; Yamaguchi K; Noda T
Cancer Sci; 2019 Apr; 110(4):1352-1363. PubMed ID: 30771244
[TBL] [Abstract][Full Text] [Related]
12. Single-cell analysis of gastric signet ring cell carcinoma reveals cytological and immune microenvironment features.
Zhao W; Jia Y; Sun G; Yang H; Liu L; Qu X; Ding J; Yu H; Xu B; Zhao S; Xing L; Chai J
Nat Commun; 2023 May; 14(1):2985. PubMed ID: 37225691
[TBL] [Abstract][Full Text] [Related]
13. RHOA mutations and CLDN18-ARHGAP fusions in intestinal-type adenocarcinoma with anastomosing glands of the stomach.
Hashimoto T; Ogawa R; Tang TY; Yoshida H; Taniguchi H; Katai H; Oda I; Sekine S
Mod Pathol; 2019 Apr; 32(4):568-575. PubMed ID: 30425335
[TBL] [Abstract][Full Text] [Related]
14. Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population-based study.
Shi T; Song X; Liu Q; Yang Y; Yu L; Liu B; Wei J
Cancer Med; 2019 Oct; 8(13):6010-6020. PubMed ID: 31448584
[TBL] [Abstract][Full Text] [Related]
15. RhoGAP domain-containing fusions and PPAPDC1A fusions are recurrent and prognostic in diffuse gastric cancer.
Yang H; Hong D; Cho SY; Park YS; Ko WR; Kim JH; Hur H; Lee J; Kim SJ; Kwon SY; Lee JH; Park DY; Song KS; Chang H; Ryu MH; Cho KS; Kang JW; Kook MC; Thiessen N; He A; Mungall A; Han SU; Kim HK
Nat Commun; 2018 Oct; 9(1):4439. PubMed ID: 30361512
[TBL] [Abstract][Full Text] [Related]
16. The percentages of signet-ring cells (SRCs) affects the prognosis after radical gastrectomy for advanced gastric cancer.
Ma Y; Wang Y; Hu C; Zi M; Chen J; Cao M; Yuan L; Yang L; Du Y
Langenbecks Arch Surg; 2023 Sep; 408(1):376. PubMed ID: 37743407
[TBL] [Abstract][Full Text] [Related]
17. Signet ring cell cancer of stomach and gastro-esophageal junction: molecular alterations, stage-stratified treatment approaches, and future challenges.
Kumar NAN; Jose A; Usman N; Rajan K; Munisamy M; Shetty PS; Rao M
Langenbecks Arch Surg; 2022 Feb; 407(1):87-98. PubMed ID: 34505199
[TBL] [Abstract][Full Text] [Related]
18. Review: Gastric cancer-Clinical aspects.
Venerito M; Link A; Rokkas T; Malfertheiner P
Helicobacter; 2019 Sep; 24 Suppl 1():e12643. PubMed ID: 31486238
[TBL] [Abstract][Full Text] [Related]
19. The characteristics and prognostic value of signet ring cell histology in gastric cancer: A retrospective cohort study of 2199 consecutive patients.
Lu M; Yang Z; Feng Q; Yu M; Zhang Y; Mao C; Shen L; Tang J
Medicine (Baltimore); 2016 Jul; 95(27):e4052. PubMed ID: 27399088
[TBL] [Abstract][Full Text] [Related]
20. CRS + HIPEC combined with IP + IV chemotherapy for gastric signet-ring cell carcinoma: Case report of long-term survival.
Yan GJ; Ji ZH; Liu G; Li Y
Medicine (Baltimore); 2020 Oct; 99(41):e22647. PubMed ID: 33031325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
